Skip to main content

BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

Written by Customer Service on . Posted in Public Companies.

Unique nootropic formula blends botanical extracts, amino acids and neuro-support nutrients to support balance, energy and resilience in athletes

LAS VEGAS, Aug. 20, 2025 (GLOBE NEWSWIRE) — via IBN – BioAdaptives, Inc. (OTCMKTS: BDPT), a leader in natural health and performance supplements, today announced that its flagship nootropic formula, MyndMed™, has been officially certified clean by TruShield™ Laboratory Services, a trusted provider of sports supplement testing specializing in World Anti-Doping Agency (WADA) compliance.

TruShield™ is widely recognized in the athletic community for its rigorous, accredited testing protocols, trusted by professional sports organizations worldwide, including the Ultimate Fighting Championship® (UFC). At the UFC’s recommendation, BioAdaptives submitted MyndMed™ to TruShield™ for comprehensive analysis to verify purity and confirm the absence of any WADA-prohibited substances.

Following extensive testing, TruShield™ has confirmed that MyndMed™ contains no banned or prohibited ingredients and meets the highest safety standards for competitive athletes. This clearance ensures that UFC athletes can use MyndMed™ with complete confidence in its compliance with anti-doping regulations.

“Athlete safety is our top priority,” said James Keener, CEO of BioAdaptives. “We always strive to produce formulas that are not only effective but also meet the highest standards of quality and compliance. TruShield™’s verification confirms that MyndMed™ can be trusted by elite athletes competing under WADA regulations.”

This approval paves the way for MyndMed™ to be integrated into the UFC’s pool of approved nutritional supplements, allowing fighters to benefit from its focus, reaction time, and cognitive performance support without risk of violating anti-doping regulations.

MyndMed™’s formula, developed by BioAdaptives’ research team, incorporates a precise blend of botanical extracts, amino acids, and neuro-support nutrients designed to support neurotransmitter balance, mitochondrial energy production, and neural resilience under the high-stress demands of professional competition.

About BioAdaptives, Inc.
BioAdaptives, Inc. develops and markets science-based natural health and wellness products for both humans and animals. Its formulations leverage cutting-edge research in stem cell biology, adaptogens, and regenerative nutrition. The company’s mission is to enhance the quality of life through innovation that works in harmony with the body’s natural processes.

For more information, visit: www.bioadaptives.com.

Contact:
Emily Harrison
Investor Relations
BioAdaptives, Inc.
(702) 659-8829
info@bioadaptives.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.